Clinical Trial Update: Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety, potential efficacy, and pharmacokinetics of PZ-601 for complicated skin and skin structure infections; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Skin Structure Infections

Drugs mentioned

• PZ-601

Snippet

Sponsor: Protez Pharmaceuticals, Inc. | Conditions: Skin Infections | Phase 2 | Status: COMPLETED